NCT07115563 - Daily Amino Acid Supplementation for People With Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

November 30, 2027

Conditions

Parkinson Disease (PD)

Interventions

DIETARY_SUPPLEMENT

Targeted Amino Acid Supplement

Blend of the essential amino acids (Leucine \& Tryptophan), a conditionally essential amino acids (Arginine \& Taurine), and non-essential amino acids (Glutamate \& Tyrosine) designed to meet the unique nutritional needs of people with Parkinson's disease (PD).

DIETARY_SUPPLEMENT

Control (placebo)

The inert amino acid (alanine) will serve as an isonitrogenous control.

Trial Locations (1)

06269

University of Connecticut, Storrs

All Listed Sponsors

collaborator

United States Department of Agriculture (USDA)

FED

lead

Cristina Colon-Semenza

OTHER